Foster GR - Search Results

1

Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection.

Foster GR, Pianko S, Brown A, Forton D, Nahass RG, George J, Barnes E, Brainard DM, Massetto B, Lin M, Han B, McHutchison JG, Subramanian GM, Cooper C, Agarwal K; BOSON Study Group. Foster GR, et al. Gastroenterology. 2015 Nov;149(6):1462-70. doi: 10.1053/j.gastro.2015.07.043. Epub 2015 Aug 4. Gastroenterology. 2015. PMID: 26248087 Clinical Trial.

2

Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha.

Booth JC, Foster GR, Kumar U, Galassini R, Goldin RD, Brown JL, Thomas HC. Booth JC, et al. Among authors: foster gr. Gut. 1995 Mar;36(3):427-32. doi: 10.1136/gut.36.3.427. Gut. 1995. PMID: 7698703 Free PMC article. Clinical Trial.

3

The relationship of histology to genotype in chronic HCV infection.

Booth JC, Foster GR, Levine T, Thomas HC, Goldin RD. Booth JC, et al. Among authors: foster gr. Liver. 1997 Jun;17(3):144-51. doi: 10.1111/j.1600-0676.1997.tb00797.x. Liver. 1997. PMID: 9249729

4

Management of chronic hepatitis C: clinical audit of biopsy based management algorithm.

Foster GR, Goldin RD, Main J, Murray-Lyon I, Hargreaves S, Thomas HC. Foster GR, et al. BMJ. 1997 Aug 23;315(7106):453-8. doi: 10.1136/bmj.315.7106.453. BMJ. 1997. PMID: 9284661 Free PMC article.

5

Amantadine in the treatment of patients with chronic hepatitis C.

Foster GR. Foster GR. Ital J Gastroenterol Hepatol. 1998 Dec;30(6):614-5. Ital J Gastroenterol Hepatol. 1998. PMID: 10076784 No abstract available.

6

Hepatitis C virus dynamics in vivo and the antiviral efficacy of interferon alfa therapy.

Thomas HC, Török ME, Foster GR. Thomas HC, et al. Among authors: foster gr. Hepatology. 1999 Apr;29(4):1333-4. doi: 10.1002/hep.510290453. Hepatology. 1999. PMID: 10094985 No abstract available.

7

Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response.

Paterson M, Laxton CD, Thomas HC, Ackrill AM, Foster GR. Paterson M, et al. Among authors: foster gr. Gastroenterology. 1999 Nov;117(5):1187-97. doi: 10.1016/s0016-5085(99)70405-1. Gastroenterology. 1999. PMID: 10535883

8

Hepatitis C virus infection: quality of life and side effects of treatment.

Foster GR. Foster GR. J Hepatol. 1999;31 Suppl 1:250-4. doi: 10.1016/s0168-8278(99)80411-5. J Hepatol. 1999. PMID: 10622597 Review.

9

Therapeutic options for HCV--management of the infected individual.

Foster GR, Thomas HC. Foster GR, et al. Baillieres Best Pract Res Clin Gastroenterol. 2000 Apr;14(2):255-64. doi: 10.1053/bega.1999.0074. Baillieres Best Pract Res Clin Gastroenterol. 2000. PMID: 10890320 Review.

10

Evidence for a cerebral effect of the hepatitis C virus.

Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Forton DM, et al. Among authors: foster gr. Lancet. 2001 Jul 7;358(9275):38-9. doi: 10.1016/S0140-6736(00)05270-3. Lancet. 2001. PMID: 11454379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page